Testing Ascensia Contour Glucometer for the Measurement of Blood Glucose

University of Zurich (UZH)

Status: Completed

Conditions: Gestational Diabetes

Treatments: Device: capillary blood glucose measurement

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT00502359

keinen

Details and patient eligibility

About

Present practice: Measurement of fasting glucose values in 2nd trimester of pregnancy, if above 4.8 mmol/l, a Glucose Tolerance Test is performed. (Two-step procedure: 1. Appointment for the fasting glucose measurement, 2. Appointment for the Glucose Tolerance Test)

Full description

Present practice: Measurement of fasting glucose values in 2nd trimester of pregnancy, if above 4.8 mmol/l, a Glucose Tolerance Test is performed. (Two-step procedure: 1. Appointment for the fasting glucose measurement, 2. Appointment for the Glucose Tolerance Test) Study: Testing of reliability and applicability of the Ascensia Contour Glucometer, Bayer. Comparison of 100 fasting glucose values measured in venous plasma by the hexokinase method in the Laboratory with 100 fasting glucose values measured in capillary whole blood on the Ascensia Contour Glucometer Outcome: If Ascensia Contour Glucometer shows applicable accuracy (narrow scatter of values), the two-step procedure should be replaced by one-step procedure: 1 only one appointment for the measurement of the fasting glucose value in capillary whole blood on Ascensia Contour Glucometer and if above 4.8 mmol/l Glucose Tolerance Test on the same day

Enrollment: 2,005 patients

Sex: Female

Volunteers: No Healthy Volunteers

Inclusion criteria

• Healthy pregnant women in 2nd Trimester of pregnancy scheduled for the measurement of fasting glucose value

Exclusion criteria

• Pregnant women with pre-existent (Type 1 or 2) diabetes or already diagnosed diabetes of pregnancy